Verismo Therapeutics: Funding, Investors & Team (Sep 2026)
Verismo Therapeutics creates new chimeric antigen receptors (CARs) that improve T-cell-based immunotherapy for cancer. Their therapy, KIR-CAR, aims to stimulate T cells naturally without causing exhaustion, specifically for treating solid tumors like pancreatic cancer, mesothelioma, and ovarian cancer.
Verismo Therapeutics has raised $49.3M across 4 funding rounds on record, the most recent an undisclosed round of $28.0M announced in Apr 2026.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Verismo Therapeutics Company Profile and Key Stats
Latest funding round on record: Apr 2026.
Verismo Therapeutics Funding Rounds
Verismo Therapeutics raised $17.0M in a Seed announced in Jul 2023.
1.2 years later, an undisclosed round of $150k was announced in Sep 2024.
4 months later, a Seed of $4.1M was announced in Jan 2025.
1.3 years later, an undisclosed round of $28.0M was announced in Apr 2026.
Verismo Therapeutics Founders and Leadership Team
Contact details for the Verismo Therapeutics team: 1 of 2 have an email address on file.
Start 14-day free trial →Verismo Therapeutics Funding Compared to Other Biotechnology Startups
Verismo Therapeutics' latest round of $28.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Verismo Therapeutics in Biotechnology and Philadelphia
Companies Similar to Verismo Therapeutics
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Verismo Therapeutics Funding FAQs
What does Verismo Therapeutics do?
Verismo Therapeutics creates new chimeric antigen receptors (CARs) that improve T-cell-based immunotherapy for cancer. Their therapy, KIR-CAR, aims to stimulate T cells naturally without causing exhaustion, specifically for treating solid tumors like pancreatic cancer, mesothelioma, and ovarian cancer.
How much funding has Verismo Therapeutics raised?
Verismo Therapeutics has raised $49.3M across 4 rounds on record. The most recent is an undisclosed round of $28.0M announced in Apr 2026.
When did Verismo Therapeutics last raise funding?
Verismo Therapeutics' most recent funding round on record is an undisclosed round of $28.0M, announced in Apr 2026.
Who founded Verismo Therapeutics?
FundedIQ lists Bryan Kim (Founder), Donald L Siegel (Founder) at Verismo Therapeutics.
Where is Verismo Therapeutics headquartered?
Verismo Therapeutics is based in Philadelphia, Pennsylvania, United States.
How many employees does Verismo Therapeutics have?
Verismo Therapeutics is in the 11-50 employee band.
How does Verismo Therapeutics' funding compare to other Biotechnology startups?
Verismo Therapeutics' latest round of $28.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Verismo Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Verismo Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.